Inhibitors | Comment | Organism | Structure |
---|---|---|---|
alpha2-antiplasmin | contributes to the inactivation of plasmin activity | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
C57BL/6J mice, SCID mice, and BALB/c mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
commercial preparation | purified enzyme | Homo sapiens | - |
plasma | - |
Homo sapiens | - |
skin | - |
Homo sapiens | - |
skin | of the ears | Mus musculus | - |
General Information | Comment | Organism |
---|---|---|
physiological function | contribution of plasmin to amplification of inflammation in patients with psoriasis. Annexin II, a receptor for plasmin is dramatically increased in both dermis and epidermis in psoriasis. Plasmin at sites of inflammation is pro-inflammatory, eliciting production of inflammatory factors, including CC chemokine ligand 20 and interleukin-23, that is mediated by the nuclear factor-kappaB (NF-kB) signaling pathway and that has an essential role in the recruitment and activation of pathogenic C-C chemokine receptor type 6+ T cells | Homo sapiens |
physiological function | plasmin, converted from plasminogen by plasminogen activators, plays an essential role in amplification of psoriasiform skin inflammation in mice. Intradermal injection of plasmin or plasmin together with recombinant monocyte/macrophage chemotactic protein-1 results in induction of psoriasiform skin inflammation around the injection sites in mice. Histological analysis of skin sections from mice treated with plasmin and rMCP-1 reveal acanthosis, hyperorthokeratosis, subcorneal microabscesses, dilated lymphatic vessels and a diffuse inflammatory infiltrates in the dermis compared to normal epidermis and dermis in the ears of control mice. Plasmin triggers NF-kB-dependent IL-23 and CCL20 expression in macrophages | Mus musculus |